Actively Recruiting
Compassionate Access of the Miltenyi Device for CD34+ Cell Selection
Led by M.D. Anderson Cancer Center · Updated on 2025-12-01
200
Participants Needed
1
Research Sites
625 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Objectives: Primary Objective To provide compassionate access to the Miltenyi device for CD34+ cell infusions to patients who experience poor graft function after stem cell transplantation (SCT).
CONDITIONS
Official Title
Compassionate Access of the Miltenyi Device for CD34+ Cell Selection
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who have poor or no graft function post stem cell transplantation.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Texas MD Anderson Cancer Center
Houston, Texas, United States, 77030
Actively Recruiting
Research Team
E
Elizabeth Shpall, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here